Publications
5674 Results
- Journal / Conference
- ASCO 12:176(#502)
- Year
- 1993
Assessment of response to new agents for primary CNS malignancies (CNS).
- Journal / Conference
- JCO 11:161-165
- Year
- 1993
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8325
Phase II trial of mitotane (o, p'DDD) and cisplatin in patients with adrenal carcinoma: A Southwest Oncology Group study.
- Journal / Conference
- JCO 11(4):644-651
- Year
- 1993
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-7204/7205, SWOG-7426/7427, SWOG-7713/14
Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapy.
- Journal / Conference
- Journal of Neurosurgery 78:909-914
- Year
- 1993
- Research Committee(s)
- Brain
- Study Number(s)
- SWOG-7983
A randomized trial of radiotherapy versus radiotherapy plus CCNU for incompletely resected low grade gliomas: A Southwest Oncology Group study.
- Journal / Conference
- NEJM 328:1002-1006
- Year
- 1993
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-8516 (INT-0067)
Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.
- Journal / Conference
- Laryngoscopy 103:64-68
- Year
- 1993
- Research Committee(s)
- Head and Neck
- Study Number(s)
- SWOG-8590 (INT-0034)
Implications of positive surgical margins.
- Journal / Conference
- Blood 81(8):2187-2193
- Year
- 1993
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-8612
A prospective randomized comparison of total body irradiation-etoposide versus busulfan-cyclophosphamide as preparatory regimens for bone marrow transplantation in patients with recurrent leukemia who were not in first remission: A Southwest Onology Group study.
- Journal / Conference
- JCO 11:1276-1285
- Year
- 1993
- Research Committee(s)
- Sarcoma
- Study Number(s)
- SWOG-8616 (INT-0072)
An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas.
- Journal / Conference
- IND 11:47-51
- Year
- 1993
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-8730
Amonafide treatment of refractory esophageal cancer: A Southwest Oncology Group study.
- Journal / Conference
- JCO 11(5):873-878
- Year
- 1993
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-8738